Small molecules, which can recognize specific transient states, can be utilized to exploit these conformational states of RNA, which can be used to inhibit RNA-associated disease mechanisms. This approach has the advantage to target a specific RNA molecule while avoiding other cellular RNAs, which is crucial in drug design as shown in HIV-1 stem-loop RNAs .